Pipelines under development

Code/ Nonproprietary Name Indication Basic research Non-clinical study Clinical study
Phase I Phase II Phase IIb Partners
① LT-1001/ PC-SOD【iv】 UC Beijing Tide
(Aug. 2007)
IPF
Stroke and MI Beijing Tide
(Aug. 2007)
ARDS, AKI, etc.
② LT-1002/ PC-SOD NE
【Nebulizer】
IPF CKD
(Aug. 2011)
COPD
③ LT-2001/ AS-013 Peripheral arterial disease Beijing Tide
(Sep. 2009)
④LT-2003/ Nano-PGE1 Peripheral arterial disease Beijing Tide
(Nov. 2010)
⑤ LT-2004/ Nano-BPS Pulmonary hypertension
⑥ LT-3001/ NSAID Inflammatory disease
⑦ LT-3002 COPD
⑧ LT-4001/
Drug re-positioning (DR)
COPD
⑨ LT-4002/
Drug re-positioning (DR)
Dry eye
⑩ LT-4004/
Drug re-positioning (DR)
EA Pharma
(Oct. 2016)
⑪ LT-4009/
Drug re-positioning (DR)
Cancer Shizuoka Univ.
(Mar. 2018)
⑫ LT-4010/
Drug re-positioning (DR)
Pulmonary fibrosis Musashino Univ.
(Jun. 2018)
⑯ LT-5001/
  Drug re-positioning (DR)
Neurology field Nobelpharma
(Mar. 2018)